Antineoplastics B-cell acute lymphoblastic leukaemia, cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1919卷 / 1期
关键词：
D O I：
10.1007/s40278-022-21004-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：62 / 62
相关论文
共 50 条
  • [31] Brexucabtagene-autoleucel/ibrutinib/lenalidomideLack of efficacy, cytokine release syndrome and Immune effector cell-associated neurotoxicity syndrome
    Reactions Weekly, 2024, 1995 (1) : 46 - 46
  • [32] Axicabtagene-ciloleucel/DexamethasoneCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: case report
    Reactions Weekly, 2024, 2025 (1) : 64 - 64
  • [33] Multiple drugsCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy
    Reactions Weekly, 2024, 2011 (1) : 269 - 269
  • [34] Bendamustine/tisagenlecleucelImmune effector cell-associated neurotoxicity syndrome: case report
    Reactions Weekly, 2022, 1926 (1) : 129 - 129
  • [35] TisagenlecleucelCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: 2 case reports
    Reactions Weekly, 2023, 1946 (1) : 515 - 515
  • [36] Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19
    Diorio, Caroline
    Shraim, Rawan
    Myers, Regina
    Behrens, Edward M.
    Canna, Scott
    Bassiri, Hamid
    Aplenc, Richard
    Burudpakdee, Chakkapong
    Chen, Fang
    DiNofia, Amanda M.
    Gill, Saar
    Gonzalez, Vanessa
    Lambert, Michele P.
    Leahy, Allison Barz
    Levine, Bruce L.
    Lindell, Robert B.
    Maude, Shannon L.
    Melenhorst, J. Joseph
    Newman, Haley
    Perazzelli, Jessica
    Seif, Alix E.
    Lacey, Simon F.
    June, Carl H.
    Barrett, David M.
    Grupp, Stephan A.
    Teachey, David T.
    CLINICAL CANCER RESEARCH, 2022, 28 (17) : 3804 - 3813
  • [37] Brexucabtagene-autoleucel/Ibrutinib/LevetiracetamImmune effector cell-associated neurotoxicity syndrome, cytokine release syndrome and lack of efficacy: case report
    Reactions Weekly, 2025, 2042 (1) : 87 - 87
  • [38] Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome
    Alix Buhlmann
    Emanuel Rom
    Giovanna Schweiger
    Dominik Schneidawind
    Sascha David
    Neurological Sciences, 2025, 46 (1) : 479 - 481
  • [39] Axicabtagene-ciloleucelImmune effector cell-associated neurotoxicity and cytokine release syndrome: 2 case reports
    Reactions Weekly, 2022, 1923 (1) : 82 - 82
  • [40] Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer
    Tanaka, Takaaki
    Taoka, Masataka
    Makimoto, Go
    Ninomiya, Kiichiro
    Higo, Hisao
    Fujii, Masanori
    Ichihara, Eiki
    Ohashi, Kadoaki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    INTERNAL MEDICINE, 2024, 63 (09) : 1261 - 1267
12345